$HCA
HCA Healthcare, Inc. · NYSE · Healthcare
- Market cap
- 87.68B
- Volume
- 929.1K
- P/E
- 13.59
- Day range
- 401.00 – 419.57
- 52w range
- 353.99 – 556.52
- Analyst target
- 451.48
AI Summary
Generating a unique summary for HCA…
AI-generated for information only — not investment advice.
Share this ticker
$HCA -1.03% at 405.00 Seth Klarman and 0 other tracked billionaires hold it. $JNJ $NTRA $LLY https://billionairestrading.com/stocks/HCA
Company summary
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Institutional ownership
Institutions hold 78.99% · insiders 16.61% · 1,864 institutions
| Holder | Shares | Value | % held | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.00M | $5.27B | 6.01% | 2026-06-30 |
| Vanguard Capital Management LLC | 10.14M | $4.11B | 4.68% | 2026-06-30 |
| Sanders Capital, LLC | 8.83M | $3.58B | 4.08% | 2026-06-30 |
| State Street Corporation | 7.47M | $3.02B | 3.45% | 2026-06-30 |
| Wellington Management Group, LLP | 4.71M | $1.91B | 2.17% | 2026-06-30 |
| Geode Capital Management, LLC | 3.67M | $1.49B | 1.69% | 2026-06-30 |
| First Eagle Investment Management, LLC | 3.30M | $1.33B | 1.52% | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.71M | $1.10B | 1.25% | 2026-06-30 |
| Morgan Stanley | 2.59M | $1.05B | 1.19% | 2026-06-30 |
| Goldman Sachs Group Inc | 2.46M | $998.05M | 1.14% | 2026-06-30 |
Hedge fund & billionaire activity
Insider transactions
| Insider | Role | Transaction | Shares | Date |
|---|---|---|---|---|
| MARKS MIKE A | Chief Financial Officer | Stock Gift at price 0.00 per share. | 3.3K | 2026-05-07 |
| MICHELSON MICHAEL W | Director | Stock Award(Grant) at price 0.00 per share. | 925.00 | 2026-04-28 |
| CHIDSEY JOHN W | Director | Stock Award(Grant) at price 0.00 per share. | 809.00 | 2026-04-28 |
| DEPARLE NANCY-ANN M. J.D. | Director | Stock Award(Grant) at price 0.00 per share. | 509.00 | 2026-04-28 |
| RILEY WAYNE JOSEPH | Director | Stock Award(Grant) at price 0.00 per share. | 509.00 | 2026-04-28 |
| SMITH ANDREA B | Director | Stock Award(Grant) at price 0.00 per share. | 509.00 | 2026-04-28 |
| FRIST THOMAS F III | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | 1.0K | 2026-04-28 |
| JOHNSTON HUGH F. | Director | Stock Award(Grant) at price 0.00 per share. | 809.00 | 2026-04-28 |
| FRIST WILLIAM R. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | 809.00 | 2026-04-28 |
| MCALEVEY MICHAEL R. | Officer | Sale at price 533.37 per share. | 1.7K | 2026-02-18 |
| MCALEVEY MICHAEL R. | Officer | Conversion of Exercise of derivative security at price 236.61 per share. | 5.0K | 2026-02-13 |
| BERRES JENNIFER | Officer | Sale at price 503.00 - 526.16 per share. | 8.0K | 2026-02-11 |
Analyst ratings
Consensus score 2.00 (1 = strong buy, 5 = sell) · mean target 451.48
- JP MorganNeutralmain2026-08-20
- Wells FargoEqual-Weightmain2026-08-03
- Goldman SachsBuymain2026-07-28
- MizuhoOutperformmain2026-07-28
- UBSBuymain2026-07-27
- Morgan StanleyUnderweightmain2026-07-27
- RBC CapitalOutperformreit2026-07-27
- Truist SecuritiesBuymain2026-07-27
- OppenheimerOutperformmain2026-07-27
- KeybancOverweightmain2026-07-27
Earnings
Next report: 2026-10-23
| Quarter | EPS actual | EPS estimate | Surprise |
|---|---|---|---|
| 3Q2025 | 6.96 | 5.73 | 1.23 |
| 4Q2025 | 8.01 | 7.48 | 0.53 |
| 1Q2026 | 7.15 | 7.13 | 0.02 |
| 2Q2026 | 7.59 | 7.50 | 0.09 |
SEC filings
- 8-KCorporate Changes & Voting Matters2026-07-29Open
- 10-QPeriodic Financial Reports2026-07-28Open
- 8-KCorporate Changes & Voting Matters2026-07-24Open
- 8-KCorporate Changes & Voting Matters2026-07-14Open
- 8-KCorporate Changes & Voting Matters2026-06-18Open
- 8-KCorporate Changes & Voting Matters2026-04-30Open
- 10-QPeriodic Financial Reports2026-04-29Open
- 8-KCorporate Changes & Voting Matters2026-04-24Open
- ARSAnnual Report to Shareholders2026-03-13Open
- 8-KCorporate Changes & Voting Matters2026-02-25Open
Latest HCA news
- The Bull Case For HCA Healthcare (HCA) Could Change Following 2026 Guidance Cut And Payer Mix Strain
HCA Healthcare recently cut its full-year 2026 earnings guidance, citing a worsening payer mix after Affordable Care Act subsidy expirations, softer high-margin elective surgeries, and rising costs that also prompted targeted corporate and support-function layoffs and at least one hospital divestiture. These actions, alongside an estimated US$400 million quarterly revenue impact from payer shifts and an ongoing legal review of prior disclosures, highlight how policy-driven reimbursement...
Sat, 05 Sep 2026 19:07:15 +0000
- HCA Healthcare (HCA) Faces Securities Fraud Investigation With Shareholder Risks In Focus
Pomerantz Law Firm has launched an investigation into potential securities fraud and unlawful business practices at HCA Healthcare (NYSE:HCA). The probe focuses on whether HCA Healthcare and certain executives misled investors or breached fiduciary duties. The investigation could lead to future legal claims on behalf of shareholders depending on its findings. This kind of legal scrutiny highlights broader questions about risk, disclosure and income reliability across the healthcare sector...
Sat, 05 Sep 2026 12:12:39 +0000
- HCA Healthcare (HCA) Could Be 11% Below Fair Value As Guidance Gets Cut
HCA Healthcare (HCA) shares remain under pressure after the company cut its 2026 profit guidance, citing a weaker payer mix that reduced quarterly revenue by about $400 million and triggered fresh investor scrutiny. Against that backdrop, HCA Healthcare’s recent share price moves have been choppy, with a 1 day share price return of 1.78% after the guidance cut, a 90 day share price return of 9.96%, and a year to date share price decline of 13.01% at a last close of US$409.20. The 3 year total...
Fri, 04 Sep 2026 20:11:23 +0000
- Is HCA Healthcare Stock Underperforming the Nasdaq?
HCA Healthcare has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Thu, 03 Sep 2026 15:52:37 +0000
- Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fri, 04 Sep 2026 15:30:28 +0000
- Community Health Systems to Participate in the Wells Fargo 21st Annual Healthcare Conference
FRANKLIN, Tenn., September 02, 2026--Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in the Wells Fargo 21st Annual Healthcare Conference to be held September 8-10, 2026.
Wed, 02 Sep 2026 15:00:00 +0000
- Form 8.3
LONDON, September 02, 2026-- FORM 8.3
Wed, 02 Sep 2026 14:25:00 +0000
- Can Ensign Group's Operating Model Drive Growth Beyond Acquisitions?
ENSG's decentralized model is driving organic growth through higher occupancy, stronger clinical results and improved productivity across its facilities.
Wed, 02 Sep 2026 13:25:00 +0000